Agreement between Medicare pharmacy claims, self‐report, and medication inventory for assessing lipid‐lowering medication use
- 29 January 2016
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 25 (7) , 827-835
Abstract
Background: Medicare claims have been used to study lipid‐lowering medication (LLM) use among US adults.Methods: We analyzed the agreement between Medicare claims for LLM and LLM use indicated by self‐report during a telephone interview and, separately, by a medication inventory performed during an in‐home study visit upon enrollment into the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. We included REGARDS participants ≥65 years enrolled in 2006–2007 with Medicare pharmacy benefits (Part D) from 120 days before their telephone interview through their medication inventory (n = 899).Results: Overall, 39.2% and 39.5% of participants had a Medicare claim for an LLM within 120 days prior to their interview and medication inventory, respectively. Also, 42.7% of participants self‐reported using LLMs, and 41.8% had an LLM in their medication inventory. The Kappa statistic (95% confidence interval [CI]) for agreement of Medicare claims with self‐report and medication inventory was 0.68 (0.63–0.73) and 0.72 (0.68–0.77), respectively. No Medicare claims for LLMs were present for 22.1% (95%CI: 18.1–26.6%) of participants who self‐reported taking LLMs and 18.9% (15.1–23.3%) with LLMs in their medication inventory. Agreement between Medicare claims and self‐report was lower among Black male individuals (Kappa = 0.34 [95%CI: 0.14–0.54]) compared with Black female individuals (0.70 [0.61–0.79]), White male individuals (0.65 [0.56–0.75]), and White female individuals (0.79 [0.72–0.86]). Agreement between Medicare claims and the medication inventory was also low among Black male individuals (Kappa = 0.48 [95%CI: 0.29–0.66]).Conclusions: Although substantial agreement exists, many Medicare beneficiaries who self‐report LLM use or have LLMs in a medication inventory have no claims for these medications. Copyright © 2016 John Wiley & Sons, Ltd.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (U01-NS041588)
- National Institutes of Health
- Department of Health and Human Service
- National, Heart, Lung and Blood Institute (R01-HL080477, K24-HL111154)
- Agency for Healthcare Research and Quality (R01-HS-8517)
This publication has 36 references indexed in Scilit:
- Cardiovascular Epidemiology in a Changing World--Challenges to Investigators and the National Heart, Lung, and Blood InstituteAmerican Journal of Epidemiology, 2012
- Accuracy of Telephone Self-Report of Drug Use in Older People and Agreement with Pharmaceutical Claims DataDrugs & Aging, 2008
- Using prescription claims data for drugs available over‐the‐counter (OTC)Pharmacoepidemiology and Drug Safety, 2007
- Agreement and validity of pharmacy data versus self-report for use of osteoporosis medications among chronic glucocorticoid usersPharmacoepidemiology and Drug Safety, 2006
- Easy SAS Calculations for Risk or Prevalence Ratios and DifferencesAmerican Journal of Epidemiology, 2005
- A review of uses of health care utilization databases for epidemiologic research on therapeuticsJournal of Clinical Epidemiology, 2005
- Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratioBMC Medical Research Methodology, 2003
- Agreement between the pharmacy medication history and patient interview for cardiovascular drugs: the Rotterdam elderly studyBritish Journal of Clinical Pharmacology, 1998
- Concurrent and Predictive Validity of a Self-reported Measure of Medication AdherenceMedical Care, 1986
- A Coefficient of Agreement for Nominal ScalesEducational and Psychological Measurement, 1960